Editas Medicine Dismisses Ernst & Young, Appoints PwC as New Auditor

On April 1, 2026, the Audit Committee of the Board of Directors of Editas Medicine, Inc. dismissed Ernst & Young LLP as the company’s independent registered public accounting firm, effective immediately. Following a thorough formal review and solicitation of proposals, the Audit Committee appointed PricewaterhouseCoopers LLP (PwC) as the new independent registered public accounting firm for the fiscal year ending December 31, 2026. The reports from Ernst & Young on the company’s consolidated financial statements for the fiscal years ended December 31, 2024, and December 31, 2025, contained no adverse opinions, disclaimers, or qualifications regarding accounting principles or audit scope. Furthermore, Editas Medicine reported that there were no disagreements or reportable events with Ernst & Young during those fiscal years or the subsequent interim period leading up to the dismissal. Ernst & Young provided a letter to the SEC, dated April 7, 2026, confirming its agreement with these disclosures. The company also confirmed it had not consulted with PwC on any accounting or auditing matters prior to their appointment.